Matches in SemOpenAlex for { <https://semopenalex.org/work/W3043669370> ?p ?o ?g. }
- W3043669370 endingPage "1061" @default.
- W3043669370 startingPage "1061" @default.
- W3043669370 abstract "Immune checkpoint inhibitors (ICIs) have demonstrated to be highly efficient in treating solid tumors; however, many patients have limited benefits in terms of response and survival. This rapidly led to the investigation of combination therapies to enhance response rates. Moreover, predictive biomarkers were assessed to better select patients. Although PD-L1 expression remains the only validated marker in clinics, molecular profiling has brought valuable information, showing that the tumor mutation load and microsatellite instability (MSI) status were associated to higher response rates in nearly all cancer types. Moreover, in lung cancer, EGFR and MET mutations, oncogene fusions or STK11 inactivating mutations were associated with low response rates. Cancer progression towards invasive phenotypes that impede immune surveillance relies on complex regulatory networks and cell interactions within the tumor microenvironment. Epigenetic modifications, such as the alteration of histone patterns, chromatin structure, DNA methylation status at specific promoters and changes in microRNA levels, may alter the cell phenotype and reshape the tumor microenvironment, allowing cells to grow and escape from immune surveillance. The objective of this review is to make an update on the identified epigenetic changes that target immune surveillance and, ultimately, ICI responses, such as histone marks, DNA methylation and miR signatures. Translational studies or clinical trials, when available, and potential epigenetic biomarkers will be discussed as perspectives in the context of combination treatment strategies to enhance ICI responses in patients with solid tumors." @default.
- W3043669370 created "2020-07-23" @default.
- W3043669370 creator A5006130660 @default.
- W3043669370 creator A5019264128 @default.
- W3043669370 creator A5022507982 @default.
- W3043669370 creator A5060265115 @default.
- W3043669370 creator A5089818289 @default.
- W3043669370 date "2020-07-16" @default.
- W3043669370 modified "2023-10-18" @default.
- W3043669370 title "Epigenetic Mechanisms of Resistance to Immune Checkpoint Inhibitors" @default.
- W3043669370 cites W1498931318 @default.
- W3043669370 cites W1517594014 @default.
- W3043669370 cites W1562763232 @default.
- W3043669370 cites W158077621 @default.
- W3043669370 cites W1873710893 @default.
- W3043669370 cites W1910012553 @default.
- W3043669370 cites W1921071413 @default.
- W3043669370 cites W1951252517 @default.
- W3043669370 cites W1962460712 @default.
- W3043669370 cites W1971208896 @default.
- W3043669370 cites W1974747095 @default.
- W3043669370 cites W1974885520 @default.
- W3043669370 cites W1976903466 @default.
- W3043669370 cites W1977144608 @default.
- W3043669370 cites W1977836335 @default.
- W3043669370 cites W1978373343 @default.
- W3043669370 cites W1978835020 @default.
- W3043669370 cites W1981463058 @default.
- W3043669370 cites W1991153319 @default.
- W3043669370 cites W1993363352 @default.
- W3043669370 cites W1994113933 @default.
- W3043669370 cites W1996487270 @default.
- W3043669370 cites W1996863944 @default.
- W3043669370 cites W1997665714 @default.
- W3043669370 cites W2004380688 @default.
- W3043669370 cites W2010461414 @default.
- W3043669370 cites W2015085911 @default.
- W3043669370 cites W2015132841 @default.
- W3043669370 cites W2021009347 @default.
- W3043669370 cites W2022143863 @default.
- W3043669370 cites W2022465587 @default.
- W3043669370 cites W2024373518 @default.
- W3043669370 cites W2027873015 @default.
- W3043669370 cites W2028638163 @default.
- W3043669370 cites W2029197798 @default.
- W3043669370 cites W2037914568 @default.
- W3043669370 cites W2040572245 @default.
- W3043669370 cites W2042699075 @default.
- W3043669370 cites W2046345187 @default.
- W3043669370 cites W2055248228 @default.
- W3043669370 cites W2057329290 @default.
- W3043669370 cites W2060070314 @default.
- W3043669370 cites W2064442490 @default.
- W3043669370 cites W2066348726 @default.
- W3043669370 cites W2068078666 @default.
- W3043669370 cites W2074643756 @default.
- W3043669370 cites W2078028724 @default.
- W3043669370 cites W2086509569 @default.
- W3043669370 cites W2094654932 @default.
- W3043669370 cites W2096083625 @default.
- W3043669370 cites W2096151993 @default.
- W3043669370 cites W2097995306 @default.
- W3043669370 cites W2100365251 @default.
- W3043669370 cites W2101653483 @default.
- W3043669370 cites W2103021272 @default.
- W3043669370 cites W2104347254 @default.
- W3043669370 cites W2105493915 @default.
- W3043669370 cites W2107484016 @default.
- W3043669370 cites W2112785261 @default.
- W3043669370 cites W2115528152 @default.
- W3043669370 cites W2117247812 @default.
- W3043669370 cites W2118203903 @default.
- W3043669370 cites W2119896120 @default.
- W3043669370 cites W2123363005 @default.
- W3043669370 cites W2125496315 @default.
- W3043669370 cites W2125616358 @default.
- W3043669370 cites W2125638543 @default.
- W3043669370 cites W2130686293 @default.
- W3043669370 cites W2131244545 @default.
- W3043669370 cites W2136708520 @default.
- W3043669370 cites W2136731993 @default.
- W3043669370 cites W2139607151 @default.
- W3043669370 cites W2141410747 @default.
- W3043669370 cites W2148706732 @default.
- W3043669370 cites W2150469988 @default.
- W3043669370 cites W2153162429 @default.
- W3043669370 cites W2153901235 @default.
- W3043669370 cites W2155464214 @default.
- W3043669370 cites W2156353875 @default.
- W3043669370 cites W2161841622 @default.
- W3043669370 cites W2162856391 @default.
- W3043669370 cites W2164360261 @default.
- W3043669370 cites W2164903177 @default.
- W3043669370 cites W2166662937 @default.
- W3043669370 cites W2168473428 @default.
- W3043669370 cites W2173135538 @default.
- W3043669370 cites W2196188512 @default.
- W3043669370 cites W2257916459 @default.